[1]
Veli YAZISIZ, İsmail UÇAR, Bengisu ASLAN, Funda ERBASAN, and Mustafa Ender TERZIOĞLU, “Onset of Inflammatory Bowel Disease Following Interleukin-17A Inhibitor Treatment”, Archives of Rheumatology, vol. 35, no. 2, pp. 300–302, Jun. 2020.